1. Introduction {#sec1-biology-09-00209}
===============

Development of antimicrobial resistance leads to the failure of clinical treatment using traditional antibiotics \[[@B1-biology-09-00209]\]. For decades, antimicrobial peptides (AMPs), discovered among all classes of living organisms from bacteria, plants, invertebrate, and vertebrate species \[[@B2-biology-09-00209]\], have attracted attention as potential novel antimicrobial alternatives \[[@B3-biology-09-00209]\]. Generally, AMPs consisting of 10 to 50 amino acids, which are cationic and amphipathic, have shown the ability to kill Gram-negative and Gram-positive bacteria, viruses, fungi, and cancer cells \[[@B4-biology-09-00209]\].

Amphibian skin secretions are a remarkable source of potentially novel therapeutic agents \[[@B5-biology-09-00209]\], and amphibian AMPs have demonstrated outstanding efficacy and kill microorganisms via a number of different mechanisms, offering the prospect of avoiding antibiotic-resistance \[[@B6-biology-09-00209]\]. The Brevinin-1 peptide family is one of the most ubiquitous AMP families \[[@B7-biology-09-00209]\], and since the first Brevinin-1 peptide with broad-spectrum antimicrobial activity was isolated from *Rana brevipoda porsa*, 985 Brevinin-1 peptides have been deposited into the database \[[@B8-biology-09-00209]\]. They share a highly conserved C-terminal disulphide bridged cyclic heptapeptide loop, namely the "Rana Box" \[[@B9-biology-09-00209]\]. Studies revealed that eliminating the disulphide bridge does not alter the biofunction remarkably \[[@B10-biology-09-00209]\], but changes to the amino acid constitution of the loop domain have a significant impact on the biological activity of brevinin-1 peptides \[[@B10-biology-09-00209],[@B11-biology-09-00209],[@B12-biology-09-00209]\]. However, a study on Brevinin-1E has shown the disulphide bridge is necessary for structural stability, but moving the "Rana box" loop from the C-terminus to the middle of the peptide did not significantly affect the antimicrobial activity \[[@B13-biology-09-00209]\].

In addition, brevinin-1 peptides have a hydrophobic N-terminal domain that is highly conserved and includes an FLP-tripeptide at the N-terminus and a Pro hinge at position 14 \[[@B10-biology-09-00209]\]. Reducing the hydrophobic domain significantly decreases antimicrobial and haemolytic activity \[[@B10-biology-09-00209]\], while changing the Pro to Ala at position 14 has been found to increase the associated cytotoxicity due to the enlargement of the helical domain \[[@B14-biology-09-00209]\].

Brevinin-1PLb and brevinin-1PLc are two previously identified brevinin-1 peptides discovered from the skin secretions of *Lithobates palustris* (*Rana palustris*), and both peptides exhibit broad-spectrum and similar antimicrobial activity \[[@B15-biology-09-00209]\]. Their biosynthetic precursor encoding cDNAs were subsequently verified by our group \[[@B16-biology-09-00209]\]. Similarly, they possess the hydrophobic N-terminal domain with the typical FLP and proline hinge motifs as well as the C-terminal heptapeptide loop. Notably, they have two FLP motifs that may contribute to the activity in the same way \[[@B14-biology-09-00209]\]. Here, we employed these brevinin-1 peptides as templates to design N-terminal truncated analogues with high efficacy and elucidate the structure--activity relationship of the N-terminal domain of brevinin-1 peptides.

2. Materials and Methods {#sec2-biology-09-00209}
========================

2.1. Fmoc Solid-Phase Peptide Synthesis {#sec2dot1-biology-09-00209}
---------------------------------------

After the authentic and unequivocal sequence was obtained, peptides (B1A and its analogues) were synthesised via the Solid Phase Peptide Synthesis (SPPS) as described previously \[[@B17-biology-09-00209]\]. Briefly, the protected group of each amino acid was removed by piperidine/N, N-dimethylformamide (DMF) (20/80, *V*/*V*). The formation of peptide chain was accomplished by 2-(1H-benzotriazole)-1, 1, 3, 3-tetramethyluronium (HBTU) in 1 M 4-methylmorpholine (NMM)/DMF solution. After that, the resin of peptide was removed by the cleavage mixture with trifluoroacetic acid (TFA), water, thioanisole (TIS), and 1, 2-ethanedithiol (EDT) (94/2/2/2; *V*/*V*/*V*). Hydrogen peroxide (H~2~O~2~) was executed to oxidise linear peptides as described previously \[[@B18-biology-09-00209]\]. Disulphide bridges were formed in the presence of 0.5% (*w*/*v*) H~2~O~2~ for 0.5 h at room temperature before lyophilisation. Each peptide was verified by LC-MS analysis and purified by RP-HPLC ([Figure S1](#app1-biology-09-00209){ref-type="app"}).

2.2. Secondary Structure Prediction and Verification {#sec2dot2-biology-09-00209}
----------------------------------------------------

The predicted physicochemical properties (sequence, amino acid number, hydrophobicity, hydrophobic moment, and net charge) and the helical wheel projections of all peptides were obtained via Heliquest \[[@B19-biology-09-00209]\]. The determination of the secondary structure of peptides was conducted using a JASCO J-815 CD Spectropolarimeter (JASCO Inc., Tokyo, Japan). The circular dichroism (CD) spectrum results were analysed by the BeStSel online server for the determination of α-helix and turn content \[[@B20-biology-09-00209]\]. The 3D models were predicted via I-TASSER online server (University of Michigan, Ann Arbor, MI, USA) \[[@B21-biology-09-00209]\].

2.3. Antimicrobial Assay {#sec2dot3-biology-09-00209}
------------------------

The antimicrobial assay was carried out to detect the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of each peptide on the microbes as described previously \[[@B22-biology-09-00209]\]. Seven different microorganisms were used in the assay: Gram-positive bacteria *Staphylococcus aur*eus (NCTC10788), *Enterococcus faecalis* (NCTC12697), and methicillin-resistant *S. aureus* (MRSA) (NCTC12493); Gram-negative bacteria *Escherichia coli* (NCTC10418), *Pseudomonas aeruginosa* (ATCC27853), and *Klebsiella pneumoniae* (ATCC 43816); and fungi *Candida albicans* (NCYC1467). Bacterial strains were inoculated and grown to mid-log phase in fresh Mueller Hinton broth (MHB) at 37 °C for overnight, then bacteria inoculum suspensions were subcultured until reaching the logarithmic growth phase by measuring OD of the cultures at wavelength 550 nm. Then, 99 µL bacteria and 1 µL peptide solution were mixed in the 96-wells microplate. For positive and negative controls, the bacteria were incubated with antibiotics (Norfloxacin for Gram-positive bacteria and Gram-negative bacteria; Amphotericin B for fungi) solution and MHB medium, respectively. Experiments were repeated five times in five replicates.

2.4. Haemolytic Assay {#sec2dot4-biology-09-00209}
---------------------

The haemolytic assay was carried out to detect the cytotoxicity of each peptide to erythrocytes obtained from fresh defibrinated horse blood as described before \[[@B23-biology-09-00209]\]. An appropriate volume of horse blood solution was collected via washing and transferring until the supernatant was clear. Then, 2% (*v*/*v*) suspension of red blood cells were incubated with peptide at 37 °C for 2 h. For positive and negative controls, the red blood cells were incubated with 1% (*v*/*v*) Triton-X 100 and Phosphate-buffered saline (PBS) solution, respectively. The 10% of maximal haemolysis concentration (HC~10~, μM) was utilised to assess the haemolytic potential. Experiments were repeated three times in five replicates.

2.5. SYTOX Green Uptake Assay {#sec2dot5-biology-09-00209}
-----------------------------

The SYTOX Green uptake assay was accomplished to detect the cell membrane permeability abilities of each peptide as described previously \[[@B22-biology-09-00209]\]. The bacterial strains were inoculated and grown to mid-log phase in fresh tryptic soy broth (TSB) medium (Sigma-Aldrich, St. Louis, MO, USA) at 37 °C overnight, and then bacteria inoculum suspensions were subcultured for 2.5 h. Bacterial cells were collected and centrifuged at 1000× *g* for 10 min at 4 °C followed by washing with 5% TSB in 0.85% NaCl solution twice. The precipitates of bacterial cells were resuspended with 5% TSB in 0.85% NaCl solution to obtain a cell concentration of 1 × 10^8^ CFU/mL by measuring OD~590~ of 0.70. The strains were incubated with peptide in several concentrations based on the MIC results. The strains were stained with SYTOX GREEN nucleic acid stain (Thermo Fisher Scientific, Waltham, MA, USA) dissolved in 5% TSB in 0.85% NaCl to a final concentration of 5 µM. The fluorescent intensity was detected with a Synergy HT plate reader (Biotech, Minneapolis, MN, USA). The fluorescence was recorded as a function of time for 2 h. For positive and negative controls, the bacteria were incubated with 32 µM Melittin solution and 0.85% NaCl solution containing 5% TSB, respectively. Experiments were repeated three times in five replicates.

2.6. Outer Membrane Permeability Assay {#sec2dot6-biology-09-00209}
--------------------------------------

The outer membrane permeability activity against Gram-negative bacteria *E. coli* was determined by the uptake of N-phenyl-1-naphthylamine (NPN) \[[@B24-biology-09-00209],[@B25-biology-09-00209]\]. Briefly, *E. coli* grew to the logarithmic phase (OD~550~ = 0.42) at 37 °C in lysogeny broth (LB) medium. Then, bacterial cells were harvested by centrifugation at 1000× *g* for 10 min at 4 °C. The cells were washed twice with 5 mM of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer containing 5 mM glucose (pH = 7.2) and resuspended to an OD~550~ of 0.2. 100 µL *E. coli* and 50 µL peptide solution were mixed with 50 µL NPN (final concentration, 10 µM). The positive control group was carried out with ethylenediaminetetraacetic acid (EDTA), and the negative control group was carried out with HEPES buffer. Black wall 96-well plates were monitored using a microplate reader (Biolise BioTek EL808, Winooski, VT, USA) at excitation and an emission wavelength of 350 nm and 420 nm, respectively. Experiments were repeated three times in five replicates.

2.7. Inner Membrane Permeability Assay {#sec2dot7-biology-09-00209}
--------------------------------------

The inner membrane permeability activity against *E. coli* bacteria was determined by the uptake of Ortho-Nitrophenyl-β-D-glucopyranoside (ONPG) as reported before \[[@B26-biology-09-00209],[@B27-biology-09-00209]\]. Briefly, *E. coli* were grown to the logarithmic phase (OD~550~ = 0.42) at 37 °C in LB medium containing 2% lactose. Then, bacterial cells were harvested by centrifugation at 1000× *g* for 10 min at 4 °C. The cells were washed twice with PBS and suspended with 10 mM PBS buffer (pH 7.4) that contained 1.5 mM ONPG to an OD~600~ of 0.05. Then, 99 µL *E. coli* and 1 µL peptide solution were incubated with 99 µL cell culture in each well of the 96-well plate. The positive control group was executed with a 32 µM Melittin solution, and the negative control group was executed with PBS buffer. The plate was detected using a microplate reader (Biolise BioTek EL808, Winooski, VT, USA) at an excitation and an emission wavelength of 350 nm and 420 nm, respectively. Experiments were repeated three times in five replicates.

2.8. Statistical Analysis {#sec2dot8-biology-09-00209}
-------------------------

Statistical analysis was executed by the GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA). Data were shown with the mean values ± SD of five replicates.

3. Results {#sec3-biology-09-00209}
==========

3.1. Rational Design of Novel Peptide {#sec3dot1-biology-09-00209}
-------------------------------------

The characteristics of brevinin-1 peptides have been generally summarised into several domains, including a hydrophobic N-terminus and C-terminal rana box. To further elucidate the amino acid constitution, motif analysis using the sequences deposited in the Antimicrobial Peptide Database (APD3) was performed by Seq2Logo algorithm. Analysis of the nine amino acid residue domain in front of the rana box loop (the "C" at position 9 in [Figure 1](#biology-09-00209-f001){ref-type="fig"}a indicates the first Cys of rana box domain) of 116 brevinin-1 sequences demonstrated that the amino acid constitution varied greatly, although most of them were hydrophobic, whilst the N-terminal tripeptide, FLP, of brevinin is highly conserved with the temporin peptide family, an AMP family from the skin secretions of Ranidae frogs ([Figure 1](#biology-09-00209-f001){ref-type="fig"}b,c).

Brevinin-1PLb (B1PLB) and brevinin-1PLc (B1PLC) exhibited high degrees of sequence identity, and both possessed potent antimicrobial activity against *S. aureus*, *E. coli*, and *C. albicans* \[[@B15-biology-09-00209]\]. Although B1PLC had better activity against bacteria, its potency was slightly lower than that of B1PLB against fungi. As we know, the more positive charge of B1PLC ([Table 1](#biology-09-00209-t001){ref-type="table"}) could contribute to an enhanced electrostatic interaction with the negatively charged bacterial cell envelope. Therefore, to try to combine the properties of the two peptides, we designed B1A by substitution of the Asn residue at position 11 in B1PLB with Lys.

In addition, B1PLB and B1PLC possess an additional FLP domain in the middle of their sequence, which is not a structural feature but is often observed in other brevinin-1 peptides. Therefore, to explore the potential function of the FLP domains, we designed two truncated analogues, B1A1 and B1A2, which had one of the two FLP segments removed and thus had either FLPLIAGLAAK or FLPKIF attached to the Rana box ([Table 1](#biology-09-00209-t001){ref-type="table"}). Both truncated peptides showed a marked decrease in antimicrobial activity as well as haemolytic activity. However, B1A2 retained weak antimicrobial activity due to the presence of the helical domain after the proline hinge. In comparison with the parent peptide, the hydrophobicity and the charge of B1A2 were drastically reduced. Thus, more analogues with enhanced charge and hydrophobicity were designed by introducing Lys residues or substituting Lys for Trp.

The analogue KB2 was created by adding a Lys residue onto the N-terminus of B1A2, and KKB2 was created by adding an additional Lys to further alter the charge. The next rationally designed analogues altered the hydrophobicity by inserting a Trp at position 5 of KB2 to create KWB2. Two further analogues, KW^3,5^B2 and KW^5,7^B2, were designed by replacing Ile^3^ and Leu^7^ with Trp in KWB2, respectively. Meanwhile, the role of hydrophobicity was examined in the same way on KKB2 by adding a Trp at position 6 (KKWB2). All these analogues share the family features ([Table 1](#biology-09-00209-t001){ref-type="table"}), the FLP motif and C-terminal "Rana Box".

3.2. Secondary Structure Analysis {#sec3dot2-biology-09-00209}
---------------------------------

To alter the hydrophobicity of these peptides, Trp was inserted into the nonpolar surface to enhance the amphiphilicity ([Figure 2](#biology-09-00209-f002){ref-type="fig"}a). B1A showed a very low propensity to form a proper alpha-helical conformation in the aqueous solution. However, it showed a very high-proportion of α-helix conformation in 1% SDS micelle solution, which is similar to the bacteria membrane environment, with the helix content of B1A estimated to represent about 66.7% of the secondary structure ([Table 2](#biology-09-00209-t002){ref-type="table"}). Compared with the parent peptide, the eight analogues ([Figure 2](#biology-09-00209-f002){ref-type="fig"}c,d) showed a low proportion of α-helical conformation in a 1% SDS micelle solution and the same random coil in aqueous solution. The secondary structure prediction via I-TASSER verified the analysis of the secondary structure to some extent ([Figure 2](#biology-09-00209-f002){ref-type="fig"}b).

3.3. Cytotoxicity {#sec3dot3-biology-09-00209}
-----------------

The haemolytic activity of B1A was quite high, with the maximal concentration causing 10% red cell lysis (HC~10~) being 1.576 µM ([Figure 3](#biology-09-00209-f003){ref-type="fig"}a). The HC~10~ was in the same order of magnitude as the MIC and the MBC ([Table 3](#biology-09-00209-t003){ref-type="table"}). In contrast, the HC~10~ of KKW^3,5^B2 was much higher at 32.07 µM, and the HC~10~s of B1A1 and B1A2 could not be calculated, as it was over the highest concentration of peptide used in these assays ([Figure 3](#biology-09-00209-f003){ref-type="fig"}a). Although all the analogues' haemolytic abilities significantly reduced, the differences among them were obvious. The relative hydrophobicities of these peptides was in the order KW^3,5^B2 \> KW^5,7^B2 \> KWB2 \> KKWB2 \> KB2 \> KKB2, and the relationship between hydrophobicity and the haemolytic assay ([Figure 3](#biology-09-00209-f003){ref-type="fig"}b) indicated that hydrophobicity ameliorated the haemolysis. Furthermore, the analysis in [Figure 3](#biology-09-00209-f003){ref-type="fig"}b exhibited that there was a linear relationship between them.

3.4. Antimicrobial Activities {#sec3dot4-biology-09-00209}
-----------------------------

The novel peptide B1A displayed potent and broad-spectrum antimicrobial activity ([Table 3](#biology-09-00209-t003){ref-type="table"}). However, the various analogues showed much more variability in their potency and in some cases were ineffective.

Both B1A1 and B1A2 showed a significant decrease in antimicrobial activity compared to the parent B1A peptide and at the concentrations used in these experiments were completely inactive against a number of microorganisms, although B1A2 retained some antimicrobial activity, possibly due to its higher hydrophobicity. KB2 displayed significantly enhanced antimicrobial activity when compared to its parent B1A2 peptide against some bacteria and fungi (*S. aureus*, *E. coli* and *C. albicans*), which demonstrated the potential contribution of charge to antimicrobial activity. Meanwhile, in comparison to KB2, KKB2, which had the additional Lys at the N-terminus, induced a two-fold improvement of antimicrobial activity against *E. coli* and a four-fold improvement against *C. albicans* but showed the same activity against the *S. aureus*. The MICs of KWB2 against *S. aureus* and *E. coli* were the same as those of KB2, but the MIC for *C. albicans* was eight-fold decreased, and there were also improvements against the other Gram-negative bacteria. The further two modifications KW^3,5^B2 and KW^5,7^B2 maintained the same results as KKB2 and KWB2 against *S. aureus* and *E. coli*, while only KW^3,5^B2 had a two-fold improvement compared to KWB2 against *C. albicans*. On the other hand, KKWB2 showed the most potent and broad-spectrum antimicrobial activities among the B1A analogues. The relationship between hydrophobicity and the MIC of four analogues with the same length in [Figure 4](#biology-09-00209-f004){ref-type="fig"} indicated a threshold of antimicrobial activity. Among those analogues, KWB2 ([Figure 4](#biology-09-00209-f004){ref-type="fig"}a) corresponded most closely to the hydrophobic threshold against Gram-positive bacteria, and KW^5,7^B2 ([Figure 4](#biology-09-00209-f004){ref-type="fig"}b) was closest against Gram-negative bacteria.

In summary, the antimicrobial activities of all the analogues were weaker than that of original peptide B1A. The therapeutic index (TI) was the ratio of HC~10~ and MIC (geometric mean), and KKWB2 had the highest therapeutic index (TI) among all the peptides examined.

3.5. The Membrane of Gram-Positive Bacteria {#sec3dot5-biology-09-00209}
-------------------------------------------

A membrane permeabilisation assay showed that B1A ([Figure 5](#biology-09-00209-f005){ref-type="fig"}a) thoroughly disrupted the cell membrane of Gram-positive bacteria at 2×MIC. However, the B1A1 and the B1A2 analogues ([Figure 5](#biology-09-00209-f005){ref-type="fig"}a,b) did not damage the cell membrane up to their respective bactericidal concentrations. None of the other analogues (KB2, KKB2, KWB2, KKWB2, KW^3,5^B2, and KW^5,7^B2) disrupted the membrane to the same extent as B1A but showed similar membrane permeabilisation abilities at 1×MIC (8 µM) against the membrane of *S. aureus.*

3.6. The Membrane of Gram-Negative Bacteria {#sec3dot6-biology-09-00209}
-------------------------------------------

KB2 and its analogues ([Figure 6](#biology-09-00209-f006){ref-type="fig"}) induced a similar level of *E. coli* inner and outer membrane permeability at their MICs. These results suggested that, even though the analogues had different antimicrobial abilities, at their MICs, they were all causing membrane permeabilisation.

4. Discussion {#sec4-biology-09-00209}
=============

Novel antimicrobial peptides could be considered as therapeutic agents to solve the complications caused by ongoing diseases and emerging disorders \[[@B28-biology-09-00209]\]. The Brevinin family is a group of peptides that have been widely studied \[[@B7-biology-09-00209]\] and found to exhibit antimicrobial activity, especially the brevinin-1 subfamily.

The two truncated analogues, B1A1 and B1A2, showed reduced antimicrobial activity, which might be related to a low degree of helicity and the attenuation of crucial antimicrobial elements such as chain length, charge number, and hydrophobicity \[[@B29-biology-09-00209]\]. The study of action mechanism assumed that the N-terminal helix could bend and insert into a bilayer to form transmembrane pore, while the C-terminal helix could attach on the lipid surface \[[@B30-biology-09-00209]\]. A secondary structural study of gaegurin-6, which has a similar sequence to B1A, indicated the Pro produced a stable kink in the molecule \[[@B31-biology-09-00209]\]. Thus, this feature was retained via the design.

In regard to antimicrobial activity, there were two parameters (charge and hydrophobicity) considered in the structure--activity relationship studies. Among the extensive reports, amino acid Arg, Lys, and Trp contribute to the antimicrobial activities of AMPs via different steps of the antimicrobial action \[[@B32-biology-09-00209]\]. An increase of Lys and Arg can enhance the electrostatic interactions with the bacterial membranes \[[@B33-biology-09-00209]\], whilst introducing Trp as a hydrophobic amino acid can improve the binding ability to the lipids, which may affect the interfacial region of the lipid bilayers \[[@B34-biology-09-00209]\]. Therefore, this suggests the substitution of Lys and Trp, which increased both the hydrophobicity and the cationic charge of the analogues, would enhance the antimicrobial activity.

Previous studies have shown that the position of Trp can affect the ability of the peptides to bind the cell membrane \[[@B35-biology-09-00209],[@B36-biology-09-00209]\]. Trp plays a unique anchoring role due to its rich content in membrane proteins near the lipid--water interface \[[@B29-biology-09-00209],[@B37-biology-09-00209],[@B38-biology-09-00209]\]. It showed that Trp near the N-terminus enhanced cell binding, while Trp near the C-terminus inhibited this action \[[@B39-biology-09-00209]\]. Meanwhile, the previous study indicated that Trp close to the N-terminus led to significant haemolytic activity \[[@B40-biology-09-00209]\]. It explained the remarkable haemolytic ability of KW^3,5^B2 on the other side. The role of Trp was also verified via the enhancement of antimicrobial activity from KB2 to KWB2 and KKB2 to KKWB2 \[[@B39-biology-09-00209]\]. Furthermore, the helicity of KW^5,7^B2 was slightly higher than that of KW^3,5^B2, which indicated that Trp closer to the N-terminal affected the formation of the helix as reported before \[[@B40-biology-09-00209]\].

Research on the antimicrobial mechanism of this family indicates Brevinin-1 peptides target the cell membrane \[[@B41-biology-09-00209]\]. Previous studies have reported a correlation between the haemolytic activity and the hydrophobicity of peptides based on models such as the "barrel-stave" model in eukaryotic cells \[[@B42-biology-09-00209]\] and the "carpet model" in prokaryotic cells \[[@B43-biology-09-00209]\]. Peptides can form a pore and penetrate the hydrophobic core of the erythrocyte membrane, causing haemolysis \[[@B43-biology-09-00209]\]. The relative hydrophobicity of the peptides examined was in the order KW^3,5^B2 \> KW^5,7^B2 \> KWB2 \> KKWB2 \> KB2 \> KKB2. The haemolytic activities of these analogues were consistent with that positive correlation that the higher the peptide hydrophobicity is, the stronger the haemolytic activity is \[[@B44-biology-09-00209],[@B45-biology-09-00209],[@B46-biology-09-00209]\]. This explained why KW^3,5^B2 exhibited the most vigorous haemolytic activity among the analogues.

We found that the charge contributed to the antibacterial ability via the antimicrobial activities of two groups: B1A2, KB2, and KKB2; KWB2 and KKWB2. The peptide in each group was designed via the addition of Lys at its N-terminus. However, in the studies looking at hydrophobicity, the results were unexpected. Eliminating interference from other variables, four analogues (KKB2, KWB2, KW^5,7^B2, and KW^3,5^B2) with the same amino acid numbers were analysed. For Gram-positive bacteria (*S. aureus*, *E. faecalis*, and MRSA) without outer-membrane structures, the hydrophobicity of KWB2 was sufficient for maximum antimicrobial activity. There was no further increase in activity with increasing hydrophobicity. Similarly, for Gram-negative bacteria (*E. coli*, *K. pneumoniae*, and *P. aeruginosa*), the hydrophobicity threshold was reached with the analogue KW^5,7^B2. Compared to Gram-positive bacteria, Gram-negative bacteria have a more complex membrane structure, which has an extra outer membrane and an abundance of highly negatively charged lipopolysaccharide \[[@B47-biology-09-00209],[@B48-biology-09-00209]\]. The peptides permeabilised the outer membrane and the inner membrane, and these processes require hydrophobicity. Thus, that may explain the reason for the higher hydrophobicity threshold for Gram-negative bacteria. Overall, these studies indicate the relative threshold of hydrophobicity for Gram-negative bacteria is higher than Gram-positive bacteria. A previous study on cyclic peptides agrees that Gram-negative bacteria need a higher threshold related to antimicrobial activity \[[@B49-biology-09-00209]\]. During that study, it was generally accepted the hydrophobicity and the antibacterial activity had a positive correlation and increasing hydrophobicity of the polar and the nonpolar faces increased the antimicrobial activity \[[@B45-biology-09-00209],[@B50-biology-09-00209]\].

A nonlinear relationship between hydrophobicity and antimicrobial activity was also mentioned in a V13K~L~ study, which had similar results \[[@B51-biology-09-00209]\]. The study attributed this phenomenon to the dimerisation of peptides. Although there are few reports on the hydrophobicity threshold, there are plenty of studies on the effect of dimerisation on the antibacterial ability of peptides. Previous research on the peptide Ctx-Ha and AU 1.2 found dimerisation decreases the antimicrobial activity \[[@B52-biology-09-00209],[@B53-biology-09-00209]\]. Higher self-association would reduce dissociation ability and weaken the ability to penetrate cell membranes and cell walls, resulting in a decrease of antibacterial ability \[[@B51-biology-09-00209]\]. Meanwhile, the self-association hinders the peptide to cross the membrane or take more cost, resulting in the inhibition of its antibacterial activity \[[@B54-biology-09-00209]\].The self-association ability is related to the hydrophobicity \[[@B51-biology-09-00209],[@B55-biology-09-00209],[@B56-biology-09-00209]\], and that may explain the results for the B1A analogues in relation to the strength of hydrophobicity.

Taken together, these results reveal a delicate balance between net charge and hydrophobicity is necessary for broad-spectrum antimicrobial activity and reduced toxicity. An increase in hydrophobicity increases haemolysis. However, these two factors (net charge and hydrophobicity) no longer promote antimicrobial activity after reaching a certain level. The charges must be up to four, which is the charge of the parent peptide B1A. Meanwhile, the hydrophobicity should reach 0.806 for the best broad-spectrum antimicrobial activity, at least in this study. However, this balance becomes more difficult to maintain if you increase the variation from the parent peptide.

5. Conclusions {#sec5-biology-09-00209}
==============

In conclusion, structure--activity relationship studies of the Brevinin-1 peptide B1A were carried out via the rational design of analogues. The results of the bio-functional studies indicate the analogue KKWB2 appears to be the best candidate peptide due to its therapeutic index. Different thresholds for hydrophobicity relating to the antimicrobial activity against different bacteria were also identified to provide new insight into peptide design and structure--activity relationship studies.

The following are available online at <https://www.mdpi.com/2079-7737/9/8/209/s1>, Figure S1: The RP-HPLC chromatograms and the mass spectra of all the synthetic peptides. B1A(a); B1A1(b); B1A2(c); KB2(d); KKB2(e); KWB2(f); KKWB2(g); KW3,5B2(h); KW5,7B2(i). The gradient of acetonitrile is indicated by the blueline.
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![Motif analysis of the selected sequences from Antimicrobial Peptide Database (APD3). The sequence cluster of (**a**) 9 amino acid residues before the rana box domain of 121 brevinin-1 peptides, (**b**) the N-terminal 6-mer peptide of selected brevinin-1 peptides, and (**c**) the N-terminal 6-mer peptide of 102 temporin peptides. The hydrophobic and positively charged amino acids are coloured by black and blue, respectively.](biology-09-00209-g001){#biology-09-00209-f001}

![(**a**) Helical wheel representation of all peptides. (**b**) Predicted 3D models of all peptides circular dichroism (CD) spectra of B1A and its analogues. The peptides were tested in aqueous solution (**c**) and 1% SDS micelles solution (**d**), respectively.](biology-09-00209-g002){#biology-09-00209-f002}

![(**a**) The haemolytic activity of novel peptides (B1A) and its analogues on horse erythrocytes. Phosphate buffered saline (PBS) and 1% TritonX-100 were used as the negative control (NC) and positive control (PC), respectively; (**b**) relationship of peptide's (KKB2, KB2, KKWB2, KWB2, KW^5,7^B2, and KW^3,5^B2) hydrophobicity and 10% haemolytic complement (HC~10~) on horse erythrocytes. Data represent means ± SD of five replicates.](biology-09-00209-g003){#biology-09-00209-f003}

###### 

Relationship of peptides' (KKB2, KWB2, KW^5,7^B2, and KW^3,5^B2) hydrophobicity in the order and MICs. (**a**) The geometric mean of the MICs for three gram-positive bacteria and their respective MICs. (**b**) The geometric mean of the MICs for three gram-negative bacteria and their respective MICs.

![](biology-09-00209-g004a)

![](biology-09-00209-g004b)

![(**a**) Cell membrane effects of B1A, B1A1, and B1A2 on *S. aureus*. (**b**) Cell membrane effects of B1A and its analogues on *S. aureus* with the same concentration. The 0.85% NaCl solution containing 5% tryptic soy broth (TSB) and 32 µM Melittin were used as negative control (NC) and positive control (PC), respectively. Data represent means ± SD of five replicates.](biology-09-00209-g005){#biology-09-00209-f005}

![(**a**) Outer membrane permeabilisation assays of E. coli by B1A and six analogues of B1A2 as indicated by the enhanced uptake of NPN. HEPES and EDTA were used as negative control (NC) and positive control (PC), respectively. (**b**) Inter membrane permeabilisation assays of E. coli by B1A and six analogues of B1A2. PBS and 32 µM Melittin were used as negative control (NC) and positive control (PC), respectively. Data represent means ± SD of five replicates.](biology-09-00209-g006){#biology-09-00209-f006}
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###### 

The physicochemical properties of Brevinin-1 peptides and B1A's analogues.

  Peptide     Sequences                  Residue No   Charge   Hydrophobicity \<H\>   Hydrophobic moment \<µH\>
  ----------- -------------------------- ------------ -------- ---------------------- ---------------------------
  B1PLB       FLPLIAGLAANFLPKIFCAITKKC   24           3        0.834                  0.310
  B1PLC       FLPVIAGVAAKFLPKIFCAITKKC   24           4        0.778                  0.352
  B1A         FLPLIAGLAAKFLPKIFCAITKKC   24           4        0.818                  0.326
  B1A1        FLPLIAGLAAKCAITKKC         18           3        0.712                  0.246
  B1A2        FLPKIFCAITKKC              13           3        0.791                  0.552
  KB2         KFLPKIFCAITKKC             14           4        0.644                  0.577
  KKB2        KKFLPKIFCAITKKC            15           5        0.553                  0.505
  KWB2        KFLPWKIFCAITKKC            15           4        0.789                  0.285
  KKWB2       KKFLPWKIFCAITKKC           16           5        0.659                  0.255
  KW^3,5^B2   KFWPWKIFCAITKKC            15           4        0.806                  0.263
  KW^5,7^B2   KFLPWKWFCAITKKC            15           4        0.799                  0.287
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###### 

Secondary structure analysis of B1A and its analogues.

  Peptide   H~2~O       1% SDS                               
  --------- ----------- -------- ------ ------ ------ ------ ------
  1         B1A         10.1     40.3   4.1    66.7   1.4    3.8
  2         B1A1        6.1      25.7   20.9   29.3   4.9    21.4
  3         B1A2        5.1      30.7   16.1   27.5   1.6    15.3
  4         KB2         10.1     21.3   17.3   20.8   9      15.2
  5         KKB2        11.4     19.0   13.8   18     30.9   15.2
  6         KWB2        11.7     23.0   14.9   20.7   13.1   15.2
  7         KKWB2       10.6     28.1   15.4   18.5   13.4   14.0
  8         KW^3,5^B2   6.3      33.7   14.0   10.3   38.3   11.2
  9         KW^5,7^B2   4.8      31.9   14.3   20.9   9.9    16.7
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###### 

Minimum inhibitory concentration (MICs), minimum bactericidal concentration (MBCs), HC~10,~ and therapeutic indices (TIs) of B1A and its analogues.

                  *S. aureus*   *E. coli*   *C. albicans*   MRSA          *E. faecalis*   *P. aeruginosa*   *K. pneumoniae*   HC~10~   TI
  --------------- ------------- ----------- --------------- ------------- --------------- ----------------- ----------------- -------- -------
  **B1A**         4/8           8/32        4/8             16/32         8/32            32/64             16/16             1.576    0.162
  **B1A1**        512/\>512     512/\>512   512/512         \>512/\>512   \>512/\>512     \>512/\>512       \>512/\>512       \>512    1
  **B1A2**        256/256       256/256     512/512         256/\>512     \>512/\>512     \>512/\>512       \>512/\>512       \>512    1.682
  **KB2**         8/64          32/64       128/512         16/128        512/\>512       512/\>512         256/256           154      1.788
  **KKB2**        8/64          16/32       32/64           16/64         512/512         256/\>512         128/256           207      3.943
  **KWB2**        8/32          16/32       16/64           8/64          256/512         128/256           64/128            99.81    3.119
  **KKWB2**       8/16          16/32       8/32            8/32          256/512         64/64             32/32             140.04   5.890
  **KW^3,5^B2**   8/16          16/32       8/32            8/32          256/256         64/128            32/64             32.07    1.349
  **KW^5,7^B2**   8/16          16/64       16/32           8/32          256/512         64/128            32/64             58.42    2.225

MICs/MBCs (µM). HC~10~ (µM). MRSA: methicillin-resistant *S. aureus*.

[^1]: These authors contributed equally to this work.
